Phocas Financial Corp’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-596,671
Closed -$6.46M 167
2026
Q1
$6.46M Buy
+596,671
New +$5.11M 1.01% 30
2025
Q1
Sell
-527,974
Closed -$4.36M 160
2024
Q4
$4.36M Buy
+527,974
New +$4.24M 0.58% 74
2023
Q4
$6.4M Buy
592,233
+123,633
+26% +$1.5M 0.85% 53
2023
Q3
$6.49M Buy
468,600
+177,645
+61% +$2.6M 0.94% 41
2023
Q2
$3.48M Sell
290,955
-1,866
-0.6% -$21.1K 0.48% 89
2023
Q1
$3.43M Buy
292,821
+2,851
+1% +$41.6K 0.49% 84
2022
Q4
$4.88M Sell
289,970
-143
-0% -$2.36K 0.7% 58
2022
Q3
$3.39M Sell
290,113
-72,169
-20% -$1.03M 0.53% 86
2022
Q2
$5.71M Sell
362,282
-415,409
-53% -$6.98M 0.86% 49
2022
Q1
$12M Buy
777,691
+377,358
+94% +$4.76M 1.5% 6
2021
Q4
$3.38M Buy
+400,333
New +$3.45M 0.43% 93

Other funds holding PTEN

Phocas Financial Corp's PTEN Position: Q2 2026 in Review

Phocas Financial Corp sold out of Patterson-UTI (PTEN) in Q2 2026, closing a stake of 596,671 shares — an estimated $6.46M sold.

Phocas Financial Corp first reported a position in PTEN in Q4 2021 and held it in 11 quarters. The position peaked at $12M in Q1 2022. 437 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Phocas Financial Corp reported no remaining Patterson-UTI position as of Q2 2026 after selling out during the quarter.
  • Phocas Financial Corp sold 596,671 Patterson-UTI shares in Q2 2026, an estimated $6.46M.
  • Phocas Financial Corp first reported a position in Patterson-UTI in Q4 2021 and held it in 11 quarters.
  • Phocas Financial Corp's Patterson-UTI position peaked at $12M in Q1 2022.
  • 437 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Phocas Financial Corp's 13F filing for Q2 2026, filed 31 Jul 2026.